|
KIAA1012 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.714020E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.384500E-02 |
| Normal-vs-Stage2 |
9.042100E-02 |
| Normal-vs-Stage3 |
1.701930E-03 |
| Normal-vs-Stage4 |
1.644320E-02 |
| Stage1-vs-Stage2 |
7.405000E-01 |
| Stage1-vs-Stage3 |
7.263800E-02 |
| Stage1-vs-Stage4 |
3.240400E-01 |
| Stage2-vs-Stage3 |
3.695200E-01 |
| Stage2-vs-Stage4 |
6.303200E-01 |
| Stage3-vs-Stage4 |
7.344600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.717100E-03 |
| Normal-vs-AfricanAmerican |
6.271000E-01 |
| Normal-vs-Asian |
1.506180E-01 |
| Caucasian-vs-AfricanAmerican |
1.410250E-01 |
| Caucasian-vs-Asian |
4.082600E-01 |
| AfricanAmerican-vs-Asian |
5.030800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.558400E-03 |
| Normal-vs-Female |
1.275600E-02 |
| Male-vs-Female |
4.684600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.198180E-01 |
| Normal-vs-Age(41-60Yrs) |
3.221100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.904270E-02 |
| Normal-vs-Age(81-100Yrs) |
6.227900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.171700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.660400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.254800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.887000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.670200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.315000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.837000E-01 |
| Classical-VS-Follicular |
8.477000E-01 |
| Classical-VS-Other |
5.203200E-01 |
| Classical-VS-Normal |
4.256300E-02 |
| Tall-VS-Follicular |
3.412200E-01 |
| Tall-VS-Other |
8.318400E-01 |
| Tall-VS-Normal |
2.084300E-02 |
| Follicular-VS-Other |
5.461400E-01 |
| Follicular-VS-Normal |
1.132840E-01 |
| Other-VS-Normal |
1.166180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.255400E-03 |
| Normal-vs-N1 |
1.231720E-02 |
| N0-vs-N1 |
5.431800E-01 |
|
|
